Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Schizophrenia

  Free Subscription


06.11.2017

1 Acta Psychiatr Scand
2 Am J Psychiatry
1 Br J Psychiatry
1 Cereb Cortex
2 Compr Psychiatry
1 J Abnorm Psychol
1 J Nerv Ment Dis
1 Mol Psychiatry
1 Neuropsychopharmacology
2 PLoS One
1 Psychiatr Clin North Am
8 Psychiatry Res
4 Psychol Med
13 Schizophr Res


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Psychiatr Scand

  1. MCCUTCHEON R, Beck K, D'Ambrosio E, Donocik J, et al
    Antipsychotic plasma levels in the assessment of poor treatment response in schizophrenia.
    Acta Psychiatr Scand. 2017 Oct 26. doi: 10.1111/acps.12825.
    PubMed     Text format     Abstract available


    Am J Psychiatry

  2. GOES FS, Sawa A
    Psychosis Beyond the 22q11.2 Deletion: Do Additional Genetic Factors Play a Role?
    Am J Psychiatry. 2017;174:1027-1029.
    PubMed     Text format    

  3. SCHOOLER NR
    Long-Term Outcomes of Psychosis: Naturalistic Follow-Up After Initial Hospitalization.
    Am J Psychiatry. 2017;174:1030-1031.
    PubMed     Text format    


    Br J Psychiatry

  4. HALL J
    Schizophrenia - an anxiety disorder?
    Br J Psychiatry. 2017;211:262-263.
    PubMed     Text format     Abstract available


    Cereb Cortex

  5. WANG C, Lee J, Ho NF, Lim JKW, et al
    Large-Scale Network Topology Reveals Heterogeneity in Individuals With at Risk Mental State for Psychosis: Findings From the Longitudinal Youth-at-Risk Study.
    Cereb Cortex. 2017 Oct 27:1-10. doi: 10.1093.
    PubMed     Text format     Abstract available


    Compr Psychiatry

  6. ALEXIADOU A, Bozikas VP, Kosmidis MH, Parlapani E, et al
    The effect of impaired verbal memory retrieval on autobiographical memory across different life periods in schizophrenia.
    Compr Psychiatry. 2017;80:81-88.
    PubMed     Text format     Abstract available

  7. CHEN L, Selvendra A, Stewart A, Castle D, et al
    Risk factors in early and late onset schizophrenia.
    Compr Psychiatry. 2017;80:155-162.
    PubMed     Text format     Abstract available


    J Abnorm Psychol

  8. OLBERT CM, Nagendra A, Buck B
    Meta-Analysis of Black vs. White Racial Disparity in Schizophrenia Diagnosis in the United States: Do Structured Assessments Attenuate Racial Disparities?
    J Abnorm Psychol. 2017 Nov 2. doi: 10.1037/abn0000309.
    PubMed     Text format     Abstract available


    J Nerv Ment Dis

  9. CARAVAGGIO F, Brucato G, Kegeles LS, Lehembre-Shiah E, et al
    Exploring the Relationship Between Body Mass Index and Positive Symptom Severity in Persons at Clinical High Risk for Psychosis.
    J Nerv Ment Dis. 2017;205:893-895.
    PubMed     Text format     Abstract available


    Mol Psychiatry

  10. RAO AR, Yourshaw M, Christensen B, Nelson SF, et al
    Rare deleterious mutations are associated with disease in bipolar disorder families.
    Mol Psychiatry. 2017;22:1009-1014.
    PubMed     Text format     Abstract available


    Neuropsychopharmacology

  11. GIRGIS RR, Ciarleglio A, Choo T, Haynes G, et al
    A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Tocilizumab, an Interleukin-6 Receptor Antibody, for Residual Symptoms in Schizophrenia.
    Neuropsychopharmacology. 2017 Nov 1. doi: 10.1038/npp.2017.
    PubMed     Text format     Abstract available


    PLoS One

  12. ABDIN E, Chong SA, Vaingankar JA, Peh CX, et al
    Trajectories of positive, negative and general psychopathology symptoms in first episode psychosis and their relationship with functioning over a 2-year follow-up period.
    PLoS One. 2017;12:e0187141.
    PubMed     Text format     Abstract available

  13. HUNG YY, Chan HY, Pan YJ
    Risk factors for readmission in schizophrenia patients following involuntary admission.
    PLoS One. 2017;12:e0186768.
    PubMed     Text format     Abstract available


    Psychiatr Clin North Am

  14. OPOKA SM, Lincoln TM
    The Effect of Cognitive Behavioral Interventions on Depression and Anxiety Symptoms in Patients with Schizophrenia Spectrum Disorders: A Systematic Review.
    Psychiatr Clin North Am. 2017;40:641-659.
    PubMed     Text format     Abstract available


    Psychiatry Res

  15. KRETCHY IA, Osafo J, Agyemang SA, Appiah B, et al
    Psychological burden and caregiver-reported non-adherence to psychotropic medications among patients with schizophrenia.
    Psychiatry Res. 2017;259:289-294.
    PubMed     Text format     Abstract available

  16. CAMPELLONE TR, Kring AM
    Anticipated pleasure for positive and negative social interaction outcomes in schizophrenia.
    Psychiatry Res. 2017;259:203-209.
    PubMed     Text format     Abstract available

  17. MARTINELLI C, Rigoli F, Dolan RJ, Shergill SS, et al
    Decreased value-sensitivity in schizophrenia.
    Psychiatry Res. 2017;259:295-301.
    PubMed     Text format     Abstract available

  18. JAJODIA A, Kaur H, Srivastava A, Kumari K, et al
    Schizophrenia susceptibility and neuregulin signaling pathway genes: A rare haplotype combination based association study in Indian population.
    Psychiatry Res. 2017 Oct 10. pii: S0165-1781(17)30253.
    PubMed     Text format    

  19. RATHEE R, Luhrmann TM, Bhatia T, Deshpande SN, et al
    Cognitive insight and objective quality of life in people with schizophrenia and auditory hallucinations.
    Psychiatry Res. 2017;259:223-228.
    PubMed     Text format     Abstract available

  20. GSPANDL S, Peirson RP, Nahhas RW, Skale TG, et al
    Comparing Global Assessment of Functioning (GAF) and World Health Organization Disability Assessment Schedule (WHODAS) 2.0 in schizophrenia.
    Psychiatry Res. 2017;259:251-253.
    PubMed     Text format     Abstract available

  21. HIRASAWA-FUJITAA M, Tudor L, Nikolac Pekovic M, Kozumplik O, et al
    Genotypic and haplotypic associations of catechol-O-methyltransferase (COMT) rs4680 and rs4818 with salivary cortisol in patients with schizophrenia.
    Psychiatry Res. 2017;259:262-264.
    PubMed     Text format    

  22. SELLERS R, Wells A, Parker S, Morrison AP, et al
    Do people with psychosis engage in unhelpful metacognitive coping strategies? A test of the validity of the Cognitive Attentional Syndrome (CAS) in a clinical sample.
    Psychiatry Res. 2017;259:243-250.
    PubMed     Text format     Abstract available


    Psychol Med

  23. ZOGHBI AW, Lieberman JA
    Alive but not well: the limited validity but continued utility of the concept of schizophrenia.
    Psychol Med. 2017 Oct 26:1-2. doi: 10.1017/S0033291717001969.
    PubMed     Text format     Abstract available

  24. BLAKEY R, Ranlund S, Zartaloudi E, Cahn W, et al
    Associations between psychosis endophenotypes across brain functional, structural, and cognitive domains.
    Psychol Med. 2017 Nov 2:1-20. doi: 10.1017/S0033291717002860.
    PubMed     Text format     Abstract available

  25. NEILSON E, Bois C, Clarke TK, Hall L, et al
    Polygenic risk for schizophrenia, transition and cortical gyrification: a high-risk study.
    Psychol Med. 2017 Oct 25:1-11. doi: 10.1017/S0033291717003087.
    PubMed     Text format     Abstract available

  26. KAHN RS
    Why the concept of schizophrenia is still alive and kicking.
    Psychol Med. 2017 Oct 26:1-2. doi: 10.1017/S0033291717002069.
    PubMed     Text format    


    Schizophr Res

  27. HUANG HK, Wang YW, Hsieh JG, Hsieh CJ, et al
    Disparity of end-of-life care in cancer patients with and without schizophrenia: A nationwide population-based cohort study.
    Schizophr Res. 2017 Oct 21. pii: S0920-9964(17)30657.
    PubMed     Text format     Abstract available

  28. BOWTELL M, Eaton S, Thien K, Bardell-Williams M, et al
    Rates and predictors of relapse following discontinuation of antipsychotic medication after a first episode of psychosis.
    Schizophr Res. 2017 Oct 21. pii: S0920-9964(17)30658.
    PubMed     Text format     Abstract available

  29. ZHENG J, Zhang Y, Li M, Liao W, et al
    Aberrant corticostriatal connectivity predict positive symptoms of antipsychotic-naive patients with adolescent-onset schizophrenia during brain maturation.
    Schizophr Res. 2017 Oct 21. pii: S0920-9964(17)30653.
    PubMed     Text format    

  30. KHAN A, Powell SB
    Sensorimotor gating deficits in "two-hit" models of schizophrenia risk factors.
    Schizophr Res. 2017 Oct 22. pii: S0920-9964(17)30618.
    PubMed     Text format     Abstract available

  31. COFFMAN BA, Haigh SM, Murphy TK, Leiter-Mcbeth J, et al
    Reduced auditory segmentation potentials in first-episode schizophrenia.
    Schizophr Res. 2017 Oct 22. pii: S0920-9964(17)30619.
    PubMed     Text format     Abstract available

  32. FOWLER D, Hodgekins J, French P
    Social Recovery Therapy in improving activity and social outcomes in early psychosis: Current evidence and longer term outcomes.
    Schizophr Res. 2017 Oct 22. pii: S0920-9964(17)30615.
    PubMed     Text format     Abstract available

  33. LEE JTM, Law EYL, Lo LLH, Lin J, et al
    Psychosocial factors associated with physical activity behavior among patients with psychosis.
    Schizophr Res. 2017 Oct 22. pii: S0920-9964(17)30604.
    PubMed     Text format     Abstract available

  34. HIRJAK D, Kubera KM, Thomann PA, Wolf RC, et al
    Motor dysfunction as an intermediate phenotype across schizophrenia and other psychotic disorders: Progress and perspectives.
    Schizophr Res. 2017 Oct 23. pii: S0920-9964(17)30616.
    PubMed     Text format     Abstract available

  35. SCHNACK HG
    Improving individual predictions: Machine learning approaches for detecting and attacking heterogeneity in schizophrenia (and other psychiatric diseases).
    Schizophr Res. 2017 Oct 24. pii: S0920-9964(17)30649.
    PubMed     Text format     Abstract available

  36. PAWELCZYK T, Piatkowska-Janko E, Bogorodzki P, Gebski P, et al
    Omega-3 fatty acid supplementation may prevent loss of gray matter thickness in the left parieto-occipital cortex in first episode schizophrenia: A secondary outcome analysis of the OFFER randomized controlled study.
    Schizophr Res. 2017 Oct 24. pii: S0920-9964(17)30621.
    PubMed     Text format     Abstract available

  37. POLIMANTI R, Gelernter J, Stein DJ
    Genetically determined schizophrenia is not associated with impaired glucose homeostasis.
    Schizophr Res. 2017 Oct 29. pii: S0920-9964(17)30661.
    PubMed     Text format     Abstract available

  38. CUESTA MJ, Moreno-Izco L, Ribeiro M, Lopez-Ilundain JM, et al
    Motor abnormalities and cognitive impairment in first-episode psychosis patients, their unaffected siblings and healthy controls.
    Schizophr Res. 2017 Oct 30. pii: S0920-9964(17)30663.
    PubMed     Text format     Abstract available

  39. GUPTA T, DeVylder JE, Auerbach RP, Schiffman J, et al
    Speech illusions and working memory performance in non-clinical psychosis.
    Schizophr Res. 2017 Oct 28. pii: S0920-9964(17)30659.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: